This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Inhaled corticosteroids and candidiasis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • oropharyngeal candidiasis causes symptoms in approximately 5% of patients

  • rate of occurrence increases with the frequency and dose of administration

  • incidence is reduced by mouth rinsing after inhalation and by use of a spacer device

Reference:

  • Drug and Therapeutics Bulletin (2000), 38 (1), 5-8.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.